The translation of 3D-printed microneedle (MN) technologies from development to routine patient use requires successful alignment of clinical performance, healthcare infrastructure, patient acceptance, and policy support. This chapter examines the pathways enabling market entry and real-world adoption of MN-based products through selected success stories and case studies. Marketed microneedle systems for vaccination and chronic pain management are discussed to illustrate practical translation and adoption trends. Key barriers to patient acceptance, like usability, education, and cultural considerations, are explored using evidence from self-administration and cross-cultural adaptation studies. The chapter further highlights the role of healthcare infrastructure and policy frameworks, with discussion of reimbursement models, clinical guidelines, and global health recommendations supporting MN integration. Finally, future commercialization pathways are examined, including emerging distributed manufacturing models that may enhance accessibility and scalability. Overall, this chapter provides insights into the critical factors influencing the successful translation of 3D-printed microneedle technologies to market and patient care.